한국어
Home › By date

Key filings, August 11, 2026

519 filings · 12 highlights
← August 10, 2026August 12, 2026 →
EarningsSwung to profitL&C BIOKOSDAQ
Operating profit
₩8.6B
Same quarter last year
-₩245M

Operating profit: swung to profit (-₩245M → ₩8.6B). Revenue ₩38.8B, up 88.5% YoY.

Q2 2026 · Separate
Company filings →Original (Korean) ↗

Supply contracts 21

8/11AmendedSphereWorth 402.3% of last year's revenue, over about 17 months.₩10.3B
8/11AmendedSphereWorth 127.5% of last year's revenue, over about 9 months.₩3.3B
8/11JNK GlobalWorth 116.3% of last year's revenue, over about 34 months.₩171B
8/11AmendedSphereWorth 57.2% of last year's revenue, over about 18 months.₩1.5B
8/11AmendedExicure HitronWorth 37.3% of last year's revenue.₩2.5B
8/11AmendedDreamCISWorth 26.6% of last year's revenue, over about 86 months.₩6.9B
8/11GigaVisWorth 21.2% of last year's revenue, over about 8 months.₩11.1B
8/11Bankware GlobalWorth 12.6% of last year's revenue, over about 19 months.₩8B
8/11Yujin RobotWorth 12.3% of last year's revenue, over about 5 months.₩3.5B
8/11CnplusWorth 8.8% of last year's revenue, over about 5 months.₩4.7B
8/11KolonWorth 8.1% of last year's revenue.₩218B
8/11KolonGlobalWorth 8.1% of last year's revenue.₩218B
8/11AmendedSamho DevelopmentWorth 7.3% of last year's revenue, over about 44 months.₩26.4B
8/11Hankook SteelWorth 6.4% of last year's revenue, over about 28 months.₩2.6B
8/11AmendedKCC Engineering & ConstructionWorth 5.7% of last year's revenue, over about 53 months.₩108B
8/11AmendedHJ Shipbuilding & ConstructionWorth 4.8% of last year's revenue.₩85.1B
8/11AmendedDL HoldingsWorth 4.5% of last year's revenue, over about 144 months.₩348B
8/11AmendedDL E&CWorth 4.5% of last year's revenue, over about 144 months.₩348B
8/11AmendedHJ Shipbuilding & ConstructionWorth 4.1% of last year's revenue, over about 66 months.₩72.7B
8/11AmendedHanshin ConstructionWorth 3.6% of last year's revenue, over about 41 months.₩47.3B
8/11DawonsysSupply contract terminated

Preliminary earnings 45

8/11Swung to profitPJ MetalOperating profit: swung to profit (-₩836M → ₩11.8B). Revenue ₩123B, up 40.9% YoY.₩11.8B
8/11Swung to profitL&C BIOOperating profit: swung to profit (-₩245M → ₩8.6B). Revenue ₩38.8B, up 88.5% YoY.₩8.6B
8/11Swung to profitShinsegae InternationalOperating profit: swung to profit (-₩7.1B → ₩7B). Revenue ₩292B, up 15.1% YoY.₩7B
8/11AmendedSwung to profitSeoul SemiconductorOperating profit: swung to profit (-₩7.9B → ₩3.5B). Revenue ₩292B, up 16.1% YoY.₩3.5B
8/11Swung to profitDentisOperating profit: swung to profit (-₩308M → ₩2.6B). Revenue ₩32.1B, down 0.8% YoY.₩2.6B
8/11Swung to profitRayenceOperating profit: swung to profit (-₩310M → ₩2.5B). Revenue ₩36.5B, up 25.7% YoY.₩2.5B
8/11PearlAbyssOperating profit ₩67.6B, up 7388.9% YoY. Revenue ₩193B, up 247.8% YoY.₩67.6B
8/11NCOperating profit ₩174B, up 1053% YoY. Revenue ₩771B, up 101.5% YoY.₩174B
8/11L&C BIOOperating profit ₩8.8B, up 624.5% YoY. Revenue ₩31.6B, up 91.7% YoY.₩8.8B
8/11JW HoldingsOperating profit ₩15.4B, up 350.7% YoY. Revenue ₩31.8B, up 67.6% YoY.₩15.4B
8/11SocarOperating profit ₩6.8B, up 271.2% YoY. Revenue ₩121B, up 22.6% YoY.₩6.8B
8/11GS HoldingsOperating profit ₩1.72T, up 253.4% YoY. Revenue ₩7.41T, up 24.9% YoY.₩1.72T
8/11KidariStudioOperating profit ₩5.5B, up 193.2% YoY. Revenue ₩64.4B, up 24.5% YoY.₩5.5B
8/11KolonGlobalOperating profit ₩52.2B, up 173.6% YoY. Revenue ₩750B, up 2.2% YoY.₩52.2B
8/11Daishin SecuritiesOperating profit ₩360B, up 165.2% YoY. Revenue ₩2.55T, up 92.9% YoY.₩360B
8/11NHNOperating profit ₩57.9B, up 164.1% YoY. Revenue ₩758B, up 25.3% YoY.₩57.9B
8/11NHN BugsOperating profit ₩496M, up 125.5% YoY. Revenue ₩10.6B, down 8.5% YoY.₩496M
8/11ShinsegaeOperating profit ₩167B, up 121.8% YoY. Revenue ₩1.78T, up 5.1% YoY.₩167B
8/11HuonsOperating profit ₩2.9B, down 77.6% YoY. Revenue ₩147B, down 5.8% YoY.₩2.9B
8/11Kyung Dong NavienOperating profit ₩84.3B, up 64.6% YoY. Revenue ₩388B, down 1% YoY.₩84.3B
8/11SHIFT UP Corporation.Operating profit ₩28.1B, down 58.8% YoY. Revenue ₩55.7B, down 50.4% YoY.₩28.1B
8/11Hankook Tire & TechnologyOperating profit ₩559B, up 58.1% YoY. Revenue ₩5.68T, up 5.8% YoY.₩559B
8/11Hwacheon MachineryOperating profit ₩905M, down 56.6% YoY. Revenue ₩56.9B, down 15.1% YoY.₩905M
8/11ValueAddedTechnologyOperating profit ₩24.5B, up 45% YoY. Revenue ₩121B, up 9.7% YoY.₩24.5B
8/11Lake MaterialsOperating profit ₩6.1B, up 40% YoY. Revenue ₩37.2B, up 19.1% YoY.₩6.1B
8/11NHNOperating profit ₩27.3B, up 36% YoY. Revenue ₩102B, up 9.9% YoY.₩27.3B
8/11HL D&I HallaOperating profit ₩26.5B, up 34.1% YoY. Revenue ₩446B, up 9.5% YoY.₩26.5B
8/11JW PharmaceuticalOperating profit ₩33.7B, up 32.7% YoY. Revenue ₩220B, up 16.1% YoY.₩33.7B
8/11Grand Korea LeisureOperating profit ₩20.8B, up 30.5% YoY. Revenue ₩120B, up 19.3% YoY.₩20.8B
8/11Dongwon MobilityOperating profit ₩13.9B, up 29.9% YoY. Revenue ₩94.3B, down 1.5% YoY.₩13.9B
8/11CJ CheiljedangOperating profit ₩258B, down 27.1% YoY. Revenue ₩7.36T, up 1.7% YoY.₩258B
8/11NHN KCPOperating profit ₩15.3B, up 26.7% YoY. Revenue ₩366B, up 29.1% YoY.₩15.3B
8/11NHN KCPOperating profit ₩15.4B, up 24.8% YoY. Revenue ₩383B, up 27.5% YoY.₩15.4B
8/11CosmaxOperating profit ₩73.7B, up 21.2% YoY. Revenue ₩795B, up 27.5% YoY.₩73.7B
8/11GwangjuShinsegae.Operating profit ₩13.9B, up 18% YoY. Revenue ₩48.4B, up 8.6% YoY.₩13.9B
8/11CJ LogisticsOperating profit ₩102B, down 11.9% YoY. Revenue ₩3.38T, up 10.9% YoY.₩102B
8/11Pum-Tech KoreaOperating profit ₩21.7B, up 11.4% YoY. Revenue ₩117B, up 10.8% YoY.₩21.7B
8/11Dongwon MobilityOperating profit ₩14.4B, up 10.4% YoY. Revenue ₩194B, up 15.3% YoY.₩14.4B
8/11KG Eco SolutionOperating profit ₩542M, down 10.4% YoY. Revenue ₩24.7B, up 41% YoY.₩542M
8/11KG Eco SolutionOperating profit ₩51.7B, up 6.9% YoY. Revenue ₩2.15T, up 19.1% YoY.₩51.7B
All preliminary earnings →

Insider trades 91

8/11BuyKoreaAlcoholIndustrial10%+ shareholder bought 78,800 sh on the market at an average ₩13,522, Aug 4–11.₩1.1B
8/11BuyIncar Financial ServiceCEO bought 90,047 sh on the market at an average ₩10,313, Aug 5–10.₩928.6M
8/11SaleYASDirector sold 138,177 sh on the market at an average ₩5,119, Aug 4.₩707.3M
8/11BuyMakus10%+ shareholder bought 32,000 sh on the market at an average ₩22,007, Aug 4–7.₩704.2M
8/11BuyChonbangAn insider bought 18,268 sh on the market at an average ₩28,970, Aug 3–11.₩529.2M
8/11BuyDaekyoCEO bought 298,796 sh on the market at an average ₩1,056, Aug 5–11.₩315.6M
8/11BuyHankook SteelCEO bought 88,000 sh on the market at an average ₩2,518, Aug 10–12.₩221.6M
8/11SaleSamsung Electronics Co,President sold 700 sh on the market at an average ₩269,214, Jul 27–Aug 4.₩188.4M
8/11BuyClean & Science10%+ shareholder bought 50,660 sh on the market at an average ₩2,932, Aug 11.₩148.5M
8/11BuyPrestige BioPharmaChairman bought 10,347 sh on the market at an average ₩6,414, Aug 4–7.₩66.4M
8/11BuySeohanDirector bought 79,478 sh on the market at an average ₩798, Jul 3–28.₩63.4M
8/11BuyESTaidDirector bought 50,000 sh on the market at an average ₩899, Aug 7.₩45M
8/11BuyAbionPresident bought 35,579 sh on the market at an average ₩1,000, Aug 11.₩35.6M
8/11BuyTHE Nature Holdings10%+ shareholder bought 5,000 sh on the market at an average ₩6,542, Aug 5–11.₩32.7M
8/11BuyHyungkuk F&BCEO bought 18,973 sh on the market at an average ₩1,106, Aug 4–7.₩21M
8/11BuyJeonjinbioCEO bought 10,000 sh on the market at an average ₩1,891, Aug 6–11.₩18.9M
8/11BuyDaejooElectronicMaterialsDirector bought 200 sh on the market at an average ₩85,400, Aug 7.₩17.1M
8/11BuySinjin SMCEO bought 6,450 sh on the market at an average ₩1,550, Aug 5–11.₩10M
8/11BuyJeongmoon InformationCEO bought 9,751 sh on the market at an average ₩909, Aug 11.₩8.9M
8/11BuyPulmuone Corporate10%+ shareholder bought 500 sh on the market at an average ₩9,262, Aug 10.₩4.6M
8/11BuyGFC Life ScienceCEO bought 497 sh on the market at an average ₩6,036, Aug 5–7.₩3M
8/11SaleHanmi Pharm.President sold 1 sh on the market at an average ₩633,000, Feb 13.₩633,000
8/11Other changeHanmi Pharm.CEO's holding rose by 102 sh (new report, other change).+102 sh
8/11Other changeHanmi Pharm.Director's holding rose by 67 sh (other change).+67 sh
8/11Other changeHanmi Pharm.President's holding rose by 528 sh (other change).+528 sh
8/11Other changeHanmi Pharm.Executive's holding rose by 31 sh (other change).+31 sh
8/11Other changeHanmi Pharm.Director's holding rose by 336 sh (other change).+336 sh
8/11Other changeHanmi Pharm.Director's holding rose by 16 sh (other change).+16 sh
8/11Other changeHanmi Pharm.Director's holding rose by 54 sh (other change).+54 sh
8/11Other changeHanmi Pharm.Executive's holding rose by 17 sh (other change).+17 sh
8/11Other changeHanmi Pharm.Director's holding rose by 86 sh (other change).+86 sh
8/11Other changeHanmi Pharm.Director's holding rose by 75 sh (other change).+75 sh
8/11Other changeHanmi Pharm.Director's holding rose by 57 sh (other change).+57 sh
8/11Other changeSK eternix10%+ shareholder's holding fell by 10,455,825 sh (off-market sale).-10,455,825 sh
8/11Other changeHanmi Pharm.Executive's holding rose by 189 sh (other change).+189 sh
8/11Other changeHanmi Pharm.Director's holding rose by 34 sh (other change).+34 sh
8/11Other changeHanmi Pharm.Director's holding rose by 60 sh (other change).+60 sh
8/11Other changeHanmi Pharm.Executive's holding rose by 21 sh (other change).+21 sh
8/11Other changeSK eternix10%+ shareholder's holding fell by 4,225,455 sh (off-market sale).-4,225,455 sh
8/11Other changeHanmi Pharm.Director's holding rose by 190 sh (other change).+190 sh
All insider trades →

5% holders 46

8/11Below 5%SK eternixA major holder's stake fell from 43.15% to 0.05%.0.05%
8/11Below 5%SK D&DA major holder's stake fell from 31.94% to 0.00% (related-party change).0.00%
8/11AmendedNew 5%InnogeneA major holder's stake rose from 0.00% to 16.63% (new report).16.63%
8/11New 5%KoasA major holder's stake rose from 0.00% to 8.15%.8.15%
8/11New 5%Satoshi HoldingsA major holder's stake rose from 0.00% to 6.82% (conversion/exercise).6.82%
8/11Heng Sheng Holding Group CompanyA major holder's stake rose from 38.00% to 54.65% (rights offering).54.65%
8/11New 5%ICDA major holder's stake rose from 0.00% to 5.81% (conversion/exercise).5.81%
8/11New 5%Lightron Fiber-Optic DevicesA major holder's stake rose from 0.00% to 5.60% (conversion/exercise).5.60%
8/11AmendedNew 5%DSMA major holder's stake rose from 0.00% to 5.27% (conversion/exercise).5.27%
8/11New 5%Woori Technology, InA major holder's stake rose from 0.00% to 5.05% (new report).5.05%
8/11New 5%HyVISION SYSTEM.A major holder's stake rose from 4.92% to 5.37% (new report).5.37%
8/11Nine & CompanyA major holder's stake fell from 22.07% to 11.69% (related-party change).11.69%
8/11New 5%BHA major holder's stake rose from 4.97% to 5.03%.5.03%
8/11Hanmi ScienceA major holder's stake fell from 13.65% to 7.58% (pledge).7.58%
8/11Hanmi ScienceA major holder's stake fell from 13.65% to 7.58% (pledge).7.58%
8/11DaekyoA major holder's stake rose from 68.71% to 72.70% (open-market buy).72.70%
8/11Below 5%NanoSilikhan Advanced MaterialsA major holder's stake fell from 7.50% to 4.24%.4.24%
8/11XavisA major holder's stake rose from 31.08% to 32.30% (open-market buy).32.30%
8/11YASA major holder's stake fell from 22.08% to 21.03% (open-market sale).21.03%
8/11Shinhan Financial GroupBlackRock's stake rose from 6.13% to 7.14% (related-party change).7.14%
8/11ChasysA major holder's stake rose from 39.59% to 40.51% (open-market buy).40.51%
8/11Hankook SteelA major holder's stake rose from 58.22% to 59.01%.59.01%
8/11Clean & ScienceA major holder's stake rose from 32.66% to 33.44% (open-market buy).33.44%
8/11SeohanA major holder's stake rose from 10.07% to 10.64%.10.64%
8/11Aprogen BiologicsA major holder's stake fell from 90.84% to 90.46% (conversion/exercise).90.46%
8/11Pulmuone CorporateA major holder's stake fell from 66.99% to 66.76% (related-party change).66.76%
8/11HVMA major holder's stake fell from 35.35% to 35.17% (pledge).35.17%
8/11Dongwha PharmA major holder's stake rose from 33.65% to 33.82%.33.82%
8/11JeonjinbioA major holder's stake rose from 8.82% to 8.93% (open-market buy).8.93%
8/11Prestige BioPharmaA major holder's stake rose from 52.33% to 52.42% (related-party change).52.42%
8/11Sinjin SMA major holder's stake rose from 50.87% to 50.95% (open-market buy).50.95%
8/11GridwizA major holder's stake rose from 29.46% to 29.50% (open-market buy).29.50%
8/11L&K BiomedA major holder's stake rose from 12.19% to 12.22% (related-party change).12.22%
8/11Kukje PharmaA major holder's stake rose from 37.93% to 37.95% (pledge).37.95%
8/11GFC Life ScienceA major holder's stake rose from 37.47% to 37.48%.37.48%
8/11HanjinkalA major holder's stake rose from 31.14% to 31.15% (related-party change).31.15%
8/11LOTTE rentalA major holder's stake rose from 61.21% to 61.21%.61.21%
8/11KnJA major holder's stake rose from 24.29% to 24.29% (pledge).24.29%
8/11Korea United PharmA major holder's stake rose from 41.90% to 41.90% (gift).41.90%
8/11KistronA major holder's stake rose from 64.05% to 64.05% (related-party change).64.05%
All 5% holders →

Buybacks 12

8/11TrustAble C&CEnded a share buyback trust contract.₩20B
8/11TrustWiSoLEnded a share buyback trust contract.₩7B
8/11TrustPentastone ElectronicsEnded a share buyback trust contract.₩5B
8/11TrustDaeryukCanEnded a share buyback trust contract.₩3B
8/11DisposalRfhicPlans to dispose of 47,900 sh of treasury stock, Aug 12 to Sep 30.₩2.6B
8/11TrustHuM&CEnded a share buyback trust contract.₩1B
8/11TrustHassSigned a ₩1B trust contract to buy back shares.₩1B
8/11BuybackInnogenePlans to buy back 726,216 sh of treasury stock, Aug 12 to Nov 11.₩1000M
8/11AmendedWiSoLShare cancellation
8/11AmendedDaeduckShare cancellation
8/11DaeduckBuyback trust ended
8/11BinggraeShare cancellation

Share issues & bonds 14

8/11AmendedRights offeringCopus KoreaIssuing 5,716,461 sh of new shares, equal to 63.7% of existing shares.₩7.5B
8/11AmendedRights offeringFantagioIssuing 2,645,502 sh of new shares, equal to 21.2% of existing shares.₩3.5B
8/11AmendedJK SynapConvertible bond issue
8/11AmendedJK SynapConvertible bond issue
8/11AmendedUnion Korea PharmRights offering
8/11AmendedUnion Korea PharmCapital reduction
8/11AmendedUnion Korea PharmRights offering
8/11AmendedMsdiConvertible bond issue
8/11AmendedCSA CosmicRights offering
8/11AmendedCSA CosmicRights offering
8/11AmendedIremRights offering
8/11AmendedClobotRights offering
8/11AmendedSensorviewRights offering
8/11AmendedSeohanBond with warrants issue

M&A & spin-offs 5

8/11Atlas LinkA ₩21.6B deal, equal to 19.2% of total assets.₩21.6B
8/11Atlas LinkA ₩13.1B deal, equal to 11.6% of total assets.₩13.1B
8/11AmendedDaou DataMerger
8/11AmendedHumaxMerger
8/11AmendedGraphyStake acquisition/disposal

Exchange actions 14

8/11SillaTextileAdministrative issue
8/11ilShinbiobaAdministrative issue
8/11KespionAdministrative issue
8/11Com2uS NTrading halt
8/11Wooree EnterpriSpin-off / split
8/11Choolip & SciencesTrading halt
8/11BillionsSpin-off / split
8/11Wooree BIOSpin-off / split
8/11Edge FoundryTrading halt
8/11EXA E&CTrading halt
8/11JNK GlobalTrading halt
8/11E-WorldInvestment caution
8/11Chinhung InternationalInvestment caution
8/11HaeinExchange inquiry